482 related articles for article (PubMed ID: 33933553)
21. METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export.
Li D; Cai L; Meng R; Feng Z; Xu Q
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121289
[TBL] [Abstract][Full Text] [Related]
22. The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1 mRNA through the MAPK pathway.
Chen JJ; Lu TZ; Wang T; Yan WH; Zhong FY; Qu XH; Gong XC; Li JG; Tou FF; Jiang LP; Han XJ
Cell Death Dis; 2024 Jun; 15(6):390. PubMed ID: 38830885
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of Long Noncoding RNA Small Nucleolar RNA Host Gene 18 Promotes Radioresistance of Glioma by Repressing Semaphorin 5A.
Zheng R; Yao Q; Ren C; Liu Y; Yang H; Xie G; Du S; Yang K; Yuan Y
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):877-887. PubMed ID: 27788958
[TBL] [Abstract][Full Text] [Related]
24. N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner.
Miao YQ; Chen W; Zhou J; Shen Q; Sun Y; Li T; Wang SC
Bioengineered; 2022 Jan; 13(1):1858-1871. PubMed ID: 35012429
[TBL] [Abstract][Full Text] [Related]
25. METTL3-Mediated lncRNA m
Song Y; Pan Y; Wu M; Sun W; Luo L; Zhao Z; Liu J
Stem Cell Rev Rep; 2021 Dec; 17(6):2276-2290. PubMed ID: 34505967
[TBL] [Abstract][Full Text] [Related]
26. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
[TBL] [Abstract][Full Text] [Related]
27. IGFBP2 expression predicts IDH-mutant glioma patient survival.
Huang LE; Cohen AL; Colman H; Jensen RL; Fults DW; Couldwell WT
Oncotarget; 2017 Jan; 8(1):191-202. PubMed ID: 27852048
[TBL] [Abstract][Full Text] [Related]
28. Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.
Wakimoto H; Tanaka S; Curry WT; Loebel F; Zhao D; Tateishi K; Chen J; Klofas LK; Lelic N; Kim JC; Dias-Santagata D; Ellisen LW; Borger DR; Fendt SM; Vander Heiden MG; Batchelor TT; Iafrate AJ; Cahill DP; Chi AS
Clin Cancer Res; 2014 Jun; 20(11):2898-909. PubMed ID: 24714777
[TBL] [Abstract][Full Text] [Related]
29. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
Wang H; Xu B; Shi J
Gene; 2020 Jan; 722():144076. PubMed ID: 31454538
[TBL] [Abstract][Full Text] [Related]
30. m
Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
[TBL] [Abstract][Full Text] [Related]
31. HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas.
Wang Y; Yi K; Liu X; Tan Y; Jin W; Li Y; Zhou J; Wang H; Kang C
Front Immunol; 2021; 12():785463. PubMed ID: 34887871
[TBL] [Abstract][Full Text] [Related]
32. Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.
Delfanti RL; Piccioni DE; Handwerker J; Bahrami N; Krishnan A; Karunamuni R; Hattangadi-Gluth JA; Seibert TM; Srikant A; Jones KA; Snyder VS; Dale AM; White NS; McDonald CR; Farid N
J Neurooncol; 2017 Dec; 135(3):601-609. PubMed ID: 28871469
[TBL] [Abstract][Full Text] [Related]
33. METTL3-Mediated m
Mao Y; Li W; Weng Y; Hua B; Gu X; Lu C; Xu B; Xu H; Wang Z
Cell Transplant; 2022; 31():9636897221122997. PubMed ID: 36073002
[TBL] [Abstract][Full Text] [Related]
34. Dynamic m
Yang F; Jin H; Que B; Chao Y; Zhang H; Ying X; Zhou Z; Yuan Z; Su J; Wu B; Zhang W; Qi D; Chen D; Min W; Lin S; Ji W
Oncogene; 2019 Jun; 38(24):4755-4772. PubMed ID: 30796352
[TBL] [Abstract][Full Text] [Related]
35. m6A RNA Methylation Controls Proliferation of Human Glioma Cells by Influencing Cell Apoptosis.
Li F; Zhang C; Zhang G
Cytogenet Genome Res; 2019; 159(3):119-125. PubMed ID: 31639789
[TBL] [Abstract][Full Text] [Related]
36. METTL3-modified lncRNA-MALAT1 regulates the molecular axis of miR-124-3p/CDK4 involved in Ewing's sarcoma.
He F; Ren T; Tang X
Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):193-197. PubMed ID: 37605570
[TBL] [Abstract][Full Text] [Related]
37. N⁶-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling.
Visvanathan A; Patil V; Abdulla S; Hoheisel JD; Somasundaram K
Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30781903
[TBL] [Abstract][Full Text] [Related]
38. The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-κB signaling.
Yu J; Shen L; Liu Y; Ming H; Zhu X; Chu M; Lin J
Mol Cell Biochem; 2020 Jan; 463(1-2):203-210. PubMed ID: 31643040
[TBL] [Abstract][Full Text] [Related]
39. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
[TBL] [Abstract][Full Text] [Related]
40. Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.
Ando K; Natsumeda M; Kawamura M; Shirakawa K; Okada M; Tsukamoto Y; Eda T; Watanabe J; Saito S; Takahashi H; Kakita A; Oishi M; Fujii Y
Thromb Res; 2023 Mar; 223():36-43. PubMed ID: 36706720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]